Applied Biometrics floats subsidiary Cardia:
This article was originally published in Clinica
Applied Biometrics is floating its wholly-owned Cardia subsidiary to its shareholders. The Minneapolis-based company is issuing one share of Cardia to those that hold 11.563 Applied shares with a further rights offering to shareholders. Following the distribution, Cardia, whose technologies include catheter introduced cardiac closure devices for use in minimally-invasive cardiac surgery, will become an independent publicly-owned company. The move is designed to allow Cardia to raise its own funds and develop its transcatheter devices.
You may also be interested in...
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.
Following closely on the heels of a medical device tax repeal win, AdvaMed CEO Scott Whitaker sat down to discuss how the industry advocacy group ended the Obamacare excise tax and what it has in store for 2020.